WHO ICTRP trial
Efficacy of Botulinum toxin A on Post herpetic Neuralgia
IRCT138812033396N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT138812033396N1 |
|---|---|
| Public title | Efficacy of Botulinum toxin A on Post herpetic Neuralgia |
| Scientific title | Efficacy of Botulinum toxin A on Post herpetic Neuralgia |
| Primary sponsor | Shiraz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Postherpetic Neuralgia. Postherpetic Neuralgia;BO2.2, G53;Postherpetic Neuralgia |
| Interventions | Intradermal injection of botolinum toxin A (15 units /every 10cm² of body involved).;Treatment - Drugs;Intradermal injection of botolinum toxin A (15 units /every 10cm² of body involved) |
| Registration date | May 19, 2010 |
| Target size | 15 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: